DJIA 17,672.60 -141.38 -0.79%
NASDAQ 4,757.88 7.48 0.16%
S&P 500 2,051.82 -11.33 -0.55%
market minute promo

Sarepta Therapeutics (NASDAQ: SRPT)

12.18 -0.05 (-0.37%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

SRPT $12.18 -0.37%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $12.19
Previous Close $12.22
Daily Range $11.97 - $12.34
52-Week Range $11.33 - $40.00
Market Cap $502.9M
P/E Ratio -4.99
Dividend (Yield) $0.00 (0.0%)
Volume 610,947
Average Daily Volume 1,199,634
Current FY EPS -$3.19





Sarepta Therapeutics (SRPT) Description

A biopharmaceutical company developing therapeutic products principally based on third-generation NEUGENE antisense technology. Website:

News & Commentary Rss Feed

State of the Union Address Investing Idea: Precision Medicine

There are plenty of companies developing precision medicine drugs already, and investors would be wise to watch key players.

Sarepta Starts Dosing in Duchenne Muscular Dystrophy Study - Analyst Blog

Sarepta Is Suffering From Overreaction

Sarepta Therapeutics Slumps: SRPT Falls 14.6% in Session - Tale of the Tape

Today's Dead Cat Bounce Stock: Sarepta Therapeutics (SRPT)

Big Short Interest On These 5 Biotech Stocks

BioMarin Shows Up Rival Sarepta During 'JPM15' Investor Presentation

Why Sarepta Theraputics Inc's Shares Crashed

Is this meaningful? Or just another movement?

Sarepta Therapeutics (SRPT) Stock Hits One-Year Low Today After Eteplirsen Update

Stocks Hitting 52-Week Lows

See More SRPT News...

SRPT's Top Competitors

SRPT $12.18 (-0.37%)
Current stock: SRPT
AMGN $159.81 (0.15%)
Current stock: AMGN
GILD $105.54 (0.38%)
Current stock: GILD
BIIB $357.63 (1.13%)
Current stock: BIIB